Agilent Technologies reported $7.37B of revenue over the trailing twelve months, +8.6% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $7.37B (to Q3 2026). Net income: $1.44B, trailing twelve months to Q3 2026. Free cash flow: $1.27B, trailing twelve months to Q3 2026. Operating margin: 22%, trailing twelve months to Q3 2026.

AAgilent Technologies

Healthcare

$170.45+34% 1Y

$170.45

$109.9952 weeks$175.27

A as reported

Agilent Technologies reported $7.37B of revenue over the trailing twelve months, +8.6% on the year before. 11 reported series are charted on this page, each one as filed.

$7.37B

Revenue, trailing twelve months · to Q3 2026 · +8.6% against the twelve months before

Net income: $1.44B
Net income · +18% year on year · trailing twelve months to Q3 2026
Free cash flow: $1.27B
Free cash flow · +16% year on year · trailing twelve months to Q3 2026
Operating margin: 22%
Operating margin · trailing twelve months to Q3 2026

Details›

Every series Ryufin has for A, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$7.37B	+8.6%	Q3 2026
Net income	$1.44B	+18%	Q3 2026
EPS	$5.07	+19%	Q3 2026
Gross margin	54%	n/a	Q3 2026
Operating margin	22%	n/a	Q3 2026
Net margin	20%	n/a	Q3 2026
ROE	19%	n/a	Q3 2026
ROA	10%	n/a	Q3 2026
ROIC	14%	n/a	Q3 2026
Free cash flow	$1.27B	+16%	Q3 2026
P/E	33.6	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.